ADAnna Mae Diehl

Anna Mae Diehl

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anna Mae Diehl has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Hedgehog signaling correlates with hepatocellular carcinoma progression

    by J. K. Sicklick, A. Jayaraman, R. Kannangai, M. S. Torbenson, M. A. Choti, A. M. Diehl

    9610 Background: Hedgehog (Hh) pathway activation promotes foregut tumors, such as pancreatic cancer. Whether Hh activity modulates hepatocellular carcinoma (HCC) pathogenesis is unknown. Although mature hepatocytes do not express the pathway, liver development requires Hh signaling. Blocking Hh prevents hepatogenesis and promotes pancreatic differentiation, suggesting a common precursor for liver and pancreas. The Hh pathway is activated when Sonic (Shh) or Indian (Ihh) ligands bind to the receptor, Patched (Ptc). When unoccupied by ligand, Ptc is a tumor suppressor because it binds Smoothened (Smo), an oncogenic protein, preventing Smo from activating Gli1. When ligand binds to Ptc, Smo is released and activates Gli1, which induces the transcription of its target gene, Ptc. Thus, Ptc mRNA levels increase with Hh activity. Aim: Determine if mRNAs of tumor suppressor (Ptc) or oncogenic (Shh, Ihh, Smo, Gli1) Hh pathway components are altered in human HCC. Methods: Total RNA was extracted from HCC and non-cancerous livers of 12 adults with HCC and various chronic liver diseases (alcoholic 8%, viral 50%, cryptogenic cirrhosis 25%). Two-step real-time PCR was done to compare expression of Shh, Ihh, Ptc, Smo, and Gli1 in HCC and non-tumor tissue from each patient. *p2-fold increase in the HCCs compared to non-tumorous liver. Regression analysis demonstrated that Smo mRNA levels correlated with HCC size*. In 8/12 (67%) HCCs, expression of the tumor suppressor, Ptc, was also significantly different than that of non-cancerous liver: 6 HCC had a 3× decrease, while 2 had an 11× increase in Ptc mRNA. Tumors with decreased Ptc were larger than HCC with normal expression (5±4 v. 3±1 cm)*. Serum levels of α-fetoprotein were barely elevated in any patient (mean 6.4±4.3 ng/mL) and did not correlate with HCC size or expression of Hh signaling components. Conclusion: Human HCCs have altered expression of Hh pathway components that regulate development of the liver from endodermal precursors. Although this pathway has been implicated in carcinogenesis of other endodermally-derived tissues, this is the first evidence for altered Hh pathway activity in hepatocarcinogenesis. No significant financial relationships to disclose.


  • Open Access

    Fatty liver, hypertension, and the metabolic syndrome

    by A M Diehl

    The prevalence of fatty liver in non-obese non-diabetic hypertensive patients is at least twice that of the general population and may be related to increases in insulin resistance and body weight.


  • Open Access

    Hepatic fibrogenesis requires sympathetic neurotransmitters

    by J A Oben, T Roskams, S Yang, H Lin, N Sinelli, M Torbenson, U Smedh, T H Moran, Z Li, J Huang, et al.

    Background and aims: Hepatic stellate cells (HSC) are activated by liver injury to become proliferative fibrogenic myofibroblasts. This process may be regulated by the sympathetic nervous system (SNS) but the mechanisms involved are unclear. Methods: We studied cultured HSC and intact mice with liver injury to test the hypothesis that HSC respond to and produce SNS neurotransmitters to promote fibrogenesis. Results: HSC expressed adrenoceptors, catecholamine biosynthetic enzymes, released norepinephrine (NE), and were growth inhibited by α- and β-adrenoceptor antagonists. HSC from dopamine β-hydroxylase deficient ( Dbh −/− ) mice, which cannot make NE, grew poorly in culture and were rescued by NE. Inhibitor studies demonstrated that this effect was mediated via G protein coupled adrenoceptors, mitogen activated kinases, and phosphatidylinositol 3-kinase. Injury related fibrogenic responses were inhibited in Dbh −/− mice, as evidenced by reduced hepatic accumulation of α-smooth muscle actin +ve HSC and decreased induction of transforming growth factor β1 (TGF-β1) and collagen. Treatment with isoprenaline rescued HSC activation. HSC were also reduced in leptin deficient ob/ob mice which have reduced NE levels and are resistant to hepatic fibrosis. Treating ob/ob mice with NE induced HSC proliferation, upregulated hepatic TGF-β1 and collagen, and increased liver fibrosis. Conclusions: HSC are hepatic neuroglia that produce and respond to SNS neurotransmitters to promote hepatic fibrosis.


  • Open Access

    Oval cells compensate for damage and replicative senescence of mature hepatocytes in mice with fatty liver disease

    by Shiqi Yang, Ayman Koteish, Huizhi Lin, Jiawen Huang, Tania Roskams, Valina Dawson, Anna Mae Diehl

    Hepatic steatosis may have a generally benign prognosis, either because most hepatocytes are not significantly injured or mechanisms to replace damaged hepatocytes are induced. To determine the relative importance of these mechanisms, we compared hepatocyte damage and replication in ethanol-fed and ob/ob mice with very indolent fatty liver disease to that of healthy control mice and PARP-1-/- mice with targeted disruption of the DNA repair enzyme, poly(ADP-ribose) polymerase. Compared to the healthy controls, both groups with fatty livers had significantly higher serum alanine aminotransferase values, hepatic mitochondrial H2O2 production, and hepatocyte oxidative DNA damage. A significantly smaller proportion of the hepatocytes from fatty livers entered S phase when cultured with mitogens. Moreover, this replicative senescence was not reversed by treating cultured hepatocytes with agents (i.e., betaine or leptin) that improve liver disease in intact ethanol-fed or leptin-deficient mice. Hepatocytes from PARP1-/- mice also had more DNA damage and reduced DNA synthesis in response to mitogens. However, neither mice with fatty livers nor PARP-1-deficient mice had atrophic livers. All of the mice with senescent mature hepatocytes exhibited hepatic accumulation of liver progenitor (oval) cells and oval cell numbers increased with the demand for hepatocyte replacement. Therefore, although hepatic oxidant production and damage are generally increased in fatty livers, expansion of hepatic progenitor cell populations helps to compensate for the increased turnover of damaged mature hepatocytes. In conclusion, these results demonstrate that induction of mechanisms to replace damaged hepatocytes is important for limiting the progression of fatty liver disease. (Hepatology 2004;39:403-411.)


  • IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines

    by Anna Mae Diehl

    Macrophage products, such as cytokines, prostanoids, nitric oxide, and reactive oxygen intermediates, influence the function and viability of macrophages and neighboring cells. Given that the liver has one of the largest resident macrophage populations in the body, it is not surprising that hepatic macrophages [i.e., Kupffer cells (KC)] are involved in the pathogenesis of many kinds of liver disease. This review summarizes the abnormalities that have been demonstrated in bone marrow, peritoneal and hepatic macrophage of leptin-resistant (fa/fa) rats and leptin-deficient (ob/ob) mice, two animal models for nonalcoholic fatty liver disease (NAFLD). Evidence supports the concept that altered KC function influences the viability of other cells, such as lymphocytes and hepatocytes, in fatty livers, thereby contributing to the pathogenesis of NAFLD in animals with reduced leptin activity. Further work is needed to determine whether KC dysfunction is a component of more generalized mechanisms that lead to NAFLD.